GRHPR Gene Hyperoxaluria Type 2 Genetic Test in UAE | 2800 AED | DHA Approved

Executive Summary & Core Metrics

Guaranteed diagnostic accuracy of 99.9% via ISO-compliant next-generation sequencing.
VIP mobile phlebotomy and temperature-controlled cold-chain home collection available daily from 8 AM to 11 PM.
Post-test telephonic clinical consultation to guide result interpretation.
Direct insurance coverage verification via WhatsApp at +971 54 548 8731.

Test Overview & Methodology

The GRHPR Gene Hyperoxaluria Type 2 Genetic Test employs next-generation sequencing (NGS) to detect pathogenic variants in the GRHPR gene, offering unparalleled accuracy for diagnosing primary hyperoxaluria type 2—a rare metabolic disorder causing recurrent kidney stones and renal failure. This test provides full gene coverage with a faster turnaround compared to traditional Sanger sequencing.

Feature	Our NGS Test	Closest Alternative (Sanger Sequencing)
Diagnostic Sensitivity	99.9% (full gene analysis)	~85% (targeted hotspot only)
Turnaround Time	3–4 Weeks	6–8 Weeks
Detection of Novel Variants	Yes (whole coding region)	Limited
Compliance	ISO 9001:2015, DHA accredited	Variable

Physician Insight & Safety Protocols

“As a Consultant Medical Genetics, I recognize the anxiety that accompanies genetic testing for a rare disorder like hyperoxaluria. This NGS‑based assay provides a definitive molecular diagnosis, but results must be interpreted in conjunction with your clinical history and family pedigree. Never modify any prescribed therapy without consulting your nephrologist.” — Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403

Important Safety Advisory

This genetic test is intended solely for diagnostic clarification. Do not discontinue any current medications, including pyridoxine, citrate supplements, or diuretics, without explicit approval from your treating physician. The test result does not replace ongoing medical management.

Exclusion Criteria & Emergency Red Flags

This test is not intended for acute emergency diagnosis; if you experience sudden severe flank pain, visible hematuria, or anuria, seek immediate emergency care.
Exclusion: Patients unable to provide informed consent, or specimens with gross hemolysis compromising DNA quality.
Genetic counseling is mandatory before sample collection; incomplete three-generation family pedigree may delay interpretation.

Patient FAQ & Clinical Guidance

1. What is the GRHPR gene and why is this test performed?

The GRHPR gene codes for glyoxylate reductase/hydroxypyruvate reductase. Pathogenic variants cause primary hyperoxaluria type 2, leading to excess oxalate production and recurrent kidney stones. This NGS test sequences the entire coding region to confirm diagnosis and guide targeted therapy.

2. How is the sample collected and is home collection available?

The specimen is a standard peripheral whole blood or buccal swab. We offer VIP mobile phlebotomy and temperature‑controlled cold‑chain home collection daily from 8 AM to 11 PM across all Emirates.

3. What do positive results mean for my health management?

A positive result confirms hereditary hyperoxaluria type 2, enabling early nephrological intervention, personalized stone prevention, and family cascade testing. Results are interpreted under DHA‑licensed clinical supervision.

UAE Regulatory & Data Privacy Adherence

This service complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is processed under strictly encrypted storage and limited access protocols. Our laboratory holds ISO 9001:2015 certification (INT/EGQ/2509DA/3139) and DHA facility license 1143. For insurance verification, WhatsApp +971 54 548 8731.

Clinical & Logistical Metadata

Test Name	GRHPR Gene Hyperoxaluria Type 2 Genetic Test
Price (AED)	2,800 AED
Turnaround Time	3–4 Weeks
Sample Type / Matrix	Whole Blood or Buccal Swab
Methodology Used	Next-Generation Sequencing (NGS) – Full Gene Analysis
ICD-10-CM Code	E72.53 (Primary hyperoxaluria type 2)
LOINC Code	101616-2 (GRHPR gene mutation analysis)
DHA Facility License & Laboratory Address	License No. 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE \| DNA Labs UAE